Skip to content
healthcare.dev

Yuviwel

NDC 73362-201, Navepegritide, kit, from Ascendis Pharma Endocrinology, Inc..

Product NDC
73362-201
Status
Listed
Labeler
Ascendis Pharma Endocrinology, Inc.
Dosage form
KIT
Route
—
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219164
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73362-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
73362-201-01733620201014 BOX in 1 CARTON (73362-201-01) / 1 KIT in 1 BOX (73362-201-02) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (73362-205-01) * 1 SOLUTION in 1 SYRINGE, GLASS (73362-801-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e01c1197-338f-414c-b804-808e129ebc8c

Use it

Look up 73362-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73362-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73362-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.